These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6128867)

  • 41. [Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
    Coma-Canella I
    Ter Arkh; 1982; 54(11):104-5. PubMed ID: 6130619
    [No Abstract]   [Full Text] [Related]  

  • 42. Ventilatory and haemodynamic effects of prenalterol and terbutaline in asthmatic patients.
    Greefhorst AP; van Herwaarden CL
    Eur J Clin Pharmacol; 1983; 24(2):173-8. PubMed ID: 6132819
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
    Shevchenko VA
    Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W; Wauer B; Isbary J
    Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inotropic effect of prenalterol in amitriptyline poisoning.
    Heath A; Mårin P; Sjöstrand I
    Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
    Reiz S; Waagstein F; Hjalmarson A
    Clin Cardiol; 1980 Apr; 3(2):96-105. PubMed ID: 6104553
    [No Abstract]   [Full Text] [Related]  

  • 48. Prenalterol as an antidote to massive doses of metoprolol--a cardiovascular study in the dog.
    Andersson T; Heath A; Mattsson H
    Acta Med Scand Suppl; 1982; 659():71-88. PubMed ID: 6127900
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 50. [Prenalterol (Hyprenan). A new cardiotonic agent].
    Pelle H; Svendsen TL; Kampmann JP
    Ugeskr Laeger; 1982 Dec; 144(49):3688-90. PubMed ID: 6133384
    [No Abstract]   [Full Text] [Related]  

  • 51. Haemodynamic and cardiac metabolic effects of the new beta 1 agonist prenalterol in patients with cardiac failure.
    Kupper W; Schütt M; Hamm CW; Kuck KH; Hanrath P; Bleifeld W
    Eur Heart J; 1983 Aug; 4(8):573-83. PubMed ID: 6139281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hemodynamic actions of prenalterol in severe congestive heart failure due to chronic coronary disease.
    Awan NA; Needham KE; Evenson MK; Win A; Mason DT
    Am Heart J; 1981 Feb; 101(2):158-61. PubMed ID: 7468416
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reversal of hypotension and bradycardia with prenalterol.
    Ostergaard D; Hüttemeier P; Pedersen T
    Anaesthesia; 1984 May; 39(5):494-5. PubMed ID: 6145369
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of beta 1-adrenoceptor stimulation and blockade studied in asthmatic airways.
    Löfdahl CG; Marlin GE; Svedmyr N
    Eur J Respir Dis Suppl; 1984; 135():151-2. PubMed ID: 6145608
    [No Abstract]   [Full Text] [Related]  

  • 55. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
    Kirlin PC; Romson JL; Pitt B; Lucchesi B
    Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT; Vatner SF; Braunwald E
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic effects of prenalterol in diabetic patients.
    Oltmanns D
    Acta Med Scand Suppl; 1982; 659():147-55. PubMed ID: 6127885
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of prenalterol in healthy subjects and patients with congestive heart failure.
    Rönn O
    Acta Med Scand Suppl; 1982; 659():89-98. PubMed ID: 6127901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [2 case reports. The use of prenalterol as an antidote to massive overdosage with beta blockaders].
    Kulling P; Eleborg L; Persson H
    Lakartidningen; 1982 Feb; 79(7):518-20. PubMed ID: 6123634
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of prenalterol on contractility, relaxation, and filling phase in coronary artery disease patients with previous myocardial infarction.
    Cucchini F; Baldi G; Bolognesi R; Ferrari R; Visioli O
    J Cardiovasc Pharmacol; 1984; 6(5):822-8. PubMed ID: 6209486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.